DRX DLY S&P Biotech Bull 3XETF
13F holders, Q2 2024 (June 30)5holders +2
2new positions
0sold out
$113.36avg. 13F price*
At the end of Q2 2024, 5 institutions reported holding DRX DLY S&P Biotech Bull 3X in their 13F filings, up 2 from Q1 2024. 2 opened new positions and 0 sold out. The largest holders were Parallel Advisors, LLC ($125K), Lindbrook Capital, LLC ($50K) and Cornerstone Planning Group LLC ($4K).
- Company
- DRX DLY S&P Biotech Bull 3X
- Filed as
- DIREXION DAILY S&P BIOTECH BULL 3X SHARES (Q2 2024)
- CUSIP
- 25490K323
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $3K |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 543 shares bought, net +543 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Parallel Advisors, LLC | 0.00% | Add +12.2% | 1,100 | $125K |
| Lindbrook Capital, LLC | 0.00% | Add +786.0% | 443 | $50K |
| Cornerstone Planning Group LLC | 0.00% | No change | 36 | $4K |
| Pension & Wealth Management Advisors, Inc. | 0.00% | New | 20 | $2K |
| Hollencrest Capital Management | 0.00% | New | 10 | $1K |
"% of holder's portfolio" is DRX DLY S&P BIOTECH BULL 3X's weight in each manager's 13F, not the share of DRX DLY S&P Biotech Bull 3X the manager owns.